Month: January 2026

Special closed-ended type private equity investment company INVL Technology, legal entity code 300893533, the registered address Gyneju str. 14 Vilnius, Lithuania (hereinafter – “the Company” or “ INVL Technology”), informs that on the initiative and decision of the management company UAB „INVL Asset Management“ (hereinafter – “the Management Company“), the Extraordinary General Shareholders Meeting (hereinafter – “the Meeting”) is to be held on 5 February 2026. The place of the Meeting: the office of the Company, the address Gyneju str. 14, Vilnius. The Meeting will start at 9:00 a.m. (registration starts at 8:30 a.m.).  The accounting day of the Meeting is 29 January 2026 (the persons who are shareholders of the Company at the end of the accounting day of the Meeting or their authorised representatives, or the persons with whom shareholders...

INVL Technology (hereinafter – “the Company”) announces its decision to call an extraordinary general meeting of shareholders at which draft resolutions on extending the Company’s term of operations and related amendments to its Articles of Association will be submitted for consideration. The Company’s current Articles of Association set out that the Company’s term of operations shall continue until 14 July 2026, with the possibility of extending that term for a period of up to 2 (two) years. It will be proposed to the extraordinary general meeting of shareholders that this possibility envisaged in the Articles of Association be made use of and that the Company’s term of operations be extended until 14 July 2028. In the assessment of the Company, some of the portfolio companies still have significant growth potential, thus extending the...

SUNNYVALE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) — Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2025 financial results ahead of its presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. Financial and Operational HighlightsFourth quarter 2025 worldwide procedures (da Vinci and Ion combined) grew approximately 18% compared with the fourth quarter of 2024. Da Vinci procedures grew approximately 17% and Ion procedures grew approximately 44%. Average da Vinci system utilization increased 4% in the fourth quarter of 2025 as compared with the fourth quarter of 2024, primarily driven by adoption of da Vinci 5 in the U.S. and continued...

ORION CORPORATION STOCK EXCHANGE RELEASE 14 JANUARY 2026 at 16:00 EET         Orion updates time estimate for the potential related to the annual Nubeqa® net sales recorded by Orion  As the company announced earlier today on 14 January 2026, the Nubeqa® product has become Orion’s largest product by far, and its financial significance for the company will increase further. For this reason, Orion decided to provide an estimate of the net sales potential of Nubeqa®. As noted earlier, based on scenario planning with partner Bayer, Orion estimates that the annual Nubeqa net sales recorded by the company (tablet sales to Bayer + royalties) has the potential to exceed EUR 1 billion in the future. It is difficult to estimate the timing for the realization of this net sales potential, as it is influenced by various changing conditions...

The binding strategic partnership agreement with Crypto.com to power event-based Prediction Markets, with a Mature Market Estimated to exceed $1 Trillion in annual trading volume1 Las Vegas, Nevada, Jan. 14, 2026 (GLOBE NEWSWIRE) — High Roller Technologies, Inc. (“High Roller”) (NYSE: ROLR), operator of the award-winning, premium online casino brands High Roller and Fruta, today announced it has entered into a binding Letter of Intent (the “LOI”) with Crypto.com | Derivatives North America (“CDNA”), for an exclusive partnership to launch an event-based prediction markets product in the United States of America. The events contracts will be offered by CDNA, a CFTC-registered exchange and clearinghouse and affiliate of Crypto.com, to customers through HighRoller.com. The partnership will offer people the opportunity to trade event...

Ra’anana, Israel, Jan. 14, 2026 (GLOBE NEWSWIRE) — Rail Vision Ltd. (Nasdaq: RVSN) (“Rail Vision” or the “Company”), an early commercialization stage technology company seeking to revolutionize railway safety and the data-related market, today announced the completion of its previously announced strategic transaction to acquire a 51% ownership interest in Quantum Transportation Ltd. (“Quantum Transportation”). Quantum Transportation holds an exclusive sub license, for rail technologies and platforms, for an innovative pending patent application in quantum error correction owned by Ramot, the technology transfer company of the Tel Aviv University. This IP and additional know-how addresses critical challenges in noisy intermediate-scale quantum devices by enabling efficient, real-time decoding of surface code errors, significantly...